Stable regular wide-complex tachycardia in the ED: how do I teach the resident to decide between synchronized cardioversion, procainamide/amiodarone, and avoiding dangerous AV nodal blockers?

Stable regular wide-complex tachycardia in the ED: how do I teach the resident to decide between synchronized cardioversion, procainamide/amiodarone, and avoiding dangerous AV nodal blockers?

Bottom line: Treat regular wide-complex tachycardia as ventricular tachycardia (VT) until proven otherwise. In any uncertainty, synchronized cardioversion is the safest definitive option; for stable monomorphic VT, procainamide is generally favored over amiodarone when EF is preserved and QT is not prolonged, while AV nodal blockers should be avoided in irregular/pre-excited rhythms because they may precipitate VF.¹³⁵

Clinical context

• Population: Adults with stable regular wide-complex tachycardia (WCT), especially monomorphic rhythms
• Setting: ED
• Decision: Electricity vs antiarrhythmic therapy vs avoiding harmful AV nodal blockade

What the best evidence says

Guidelines / consensus

• WikEM/ACLS approach: assume any WCT is VT until proven otherwise because it is safer to overcall VT than mislabel SVT with aberrancy.¹³
• Stable regular monomorphic WCT:
  • Procainamide is listed as first-line drug therapy.¹³
  • Amiodarone is preferred when acute MI or LV dysfunction is present.¹³
  • Adenosine may be considered only if the rhythm is regular and monomorphic.¹³
  • Synchronized cardioversion remains an acceptable and highly effective option.¹³
• Wide irregular tachycardia/pre-excited AF:
  • Do not use AV nodal blockers because they can precipitate VF.¹³

Key trials / studies

• PROCAMIO trial: Randomized comparison of IV procainamide vs IV amiodarone in tolerated wide-QRS tachycardia.¹⁵
  • Intervention vs control: Procainamide vs amiodarone
  • Primary outcome: VT termination was higher with procainamide (67% vs 38%) and adverse cardiac events were lower (9% vs 41%).¹
  • Limitations: Stable/tolerated VT populations; broader applicability uncertain.⁵
• Systematic reviews/retrospective data: Procainamide conversion rates estimated ~50–80% vs ~30% for amiodarone in stable monomorphic VT.⁴
  • Limitations: Mostly retrospective studies, small samples, heterogeneous inclusion criteria.⁴⁵

How to apply at bedside

• Use synchronized cardioversion if:

  • Any instability develops: hypotension, altered mental status, ischemic chest discomfort, shock, acute heart failure.¹³
  • Rhythm diagnosis is uncertain
  • Drug therapy fails
  • You want the fastest/highest-efficacy treatment.⁴⁵

• Use procainamide if:

  • Stable monomorphic regular WCT
  • Preserved EF/no CHF
  • No prolonged QT.¹³
  • Typical dosing: 20–50 mg/min until suppression (max 17 mg/kg or 1 g), or 100 mg every 5 minutes at 25–50 mg/min.¹³

• Avoid/stop procainamide if:

  • Hypotension develops
  • QRS widens >50%
  • Prolonged QT or CHF present.¹³

• Use amiodarone if:

  • Suspected acute MI or LV dysfunction/poor EF.¹³
  • Dose: 150 mg IV over 10 minutes, then infusion.¹³

• Consider adenosine only if:

  • Rhythm is regular and monomorphic
  • Diagnostic uncertainty between VT and SVT with aberrancy exists.¹²³

• Avoid AV nodal blockers if:

  • Rhythm is irregular wide-complex
  • Pre-excited AF/WPW is possible.¹²³

• Shared decision-making points:

  • Cardioversion is usually the most reliable and rapid therapy.⁴⁵
  • Antiarrhythmics may avoid sedation/shock but can cause hypotension and treatment failure.⁴⁵

Controversies / uncertainty

• Distinguishing VT from SVT with aberrancy is often difficult in real time; multiple ECG rules exist but are hard to apply during acute care.²
• Amiodarone remains commonly used despite evidence favoring procainamide in stable monomorphic VT.⁴⁵
• Literature comparing antiarrhythmics is limited by small studies and heterogeneous patient populations.⁵

Practical approach (suggested)

1. Teach residents to first ask:
   • Is the patient unstable?
   • Is the rhythm regular or irregular?
   • Is the QRS wide or narrow?¹
2. For stable regular monomorphic WCT:
   • Assume VT
   • Pads on
   • Prepare for synchronized cardioversion
   • Use procainamide preferentially if EF preserved and QT normal; use amiodarone if LV dysfunction/AMI suspected.¹³
3. If rhythm is irregular wide-complex or WPW/pre-excitation suspected:
   • Avoid AV nodal blockers
   • Use electricity or procainamide-based strategies.¹²³
4. If uncertain at any point, cardiovert.²⁴